Literature DB >> 23184310

The influence of age on the recovery of the ERG photostress test.

D Messenio1, G Marano, S Gerosa, F Iannelli, E M Biganzoli.   

Abstract

INTRODUCTION: Focal ERG associated with photostress test could be a useful diagnostic method for evaluating macular visual function. The main aim of this study was to evaluate the effect of age on the recovery time constant of the ERG photostress test. The second aim was to assess the sources of variability which affect the measurements.
METHODS: Fifty-four healthy subjects (108 eyes), aged between 21 and 77, with corrected VA of 20/20 or more and absence of any ocular or systemic disease, were recruited. For each eye ERG response to focal (20° in diameter) 42-Hz stimulation was recorded: three series of 200 summations in base conditions and a six series of 42-Hz ERGs (100 summations each) at 10, 40, 80, 180, 300 and 420 s after bleaching by a white spot of light (20° in diameter) from a direct ophthalmoscope (800 cd/m²) pointed at macular region for 30 s. Fourier analysis was performed and amplitude of the first harmonica calculated. The relationship of basal amplitudes with subject age and gender, and the kinetics of macular function recovery were assessed through mixed-effects models.
RESULTS: Mean basal amplitude decreases by 0.046 μV for year of life. The recovery after bleaching is proportional to age with an increase of 4.31 s for decade. Restoration of amplitude is slower in older subjects. DISCUSSION: There is a significant decrease in macular ERG amplitude with age. The macular recovery after photostress shows exponential kinetics that are less efficient in older subjects: this could be related to lower effectiveness of photopigment restoration in advanced age.

Entities:  

Mesh:

Year:  2012        PMID: 23184310     DOI: 10.1007/s10633-012-9361-y

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  20 in total

1.  Sources of variability in the clinical photostress test.

Authors:  Tom H Margrain; David Thomson
Journal:  Ophthalmic Physiol Opt       Date:  2002-01       Impact factor: 3.117

2.  Loss of cone function in age-related maculopathy.

Authors:  Joanna A Phipps; Robyn H Guymer; Algis J Vingrys
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-05       Impact factor: 4.799

3.  Recovery of the human photopic electroretinogram after bleaching exposures: estimation of pigment regeneration kinetics.

Authors:  O A R Mahroo; T D Lamb
Journal:  J Physiol       Date:  2003-10-31       Impact factor: 5.182

4.  Evaluation of retinal function using the Dynamic Focal Cone ERG.

Authors:  Alison Binns; Tom H Margrain
Journal:  Ophthalmic Physiol Opt       Date:  2005-11       Impact factor: 3.117

5.  Evaluating retinal function in age-related maculopathy with the ERG photostress test.

Authors:  Alison M Binns; Tom H Margrain
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-06       Impact factor: 4.799

6.  Foveal dark adaptation, photopigment regeneration, and aging.

Authors:  D C Coile; H D Baker
Journal:  Vis Neurosci       Date:  1992-01       Impact factor: 3.241

7.  Measuring rod and cone dynamics in age-related maculopathy.

Authors:  Peter N Dimitrov; Robyn H Guymer; Andrew J Zele; Andrew J Anderson; Algis J Vingrys
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-01       Impact factor: 4.799

8.  Electrical Responses of the Human Eye to Moving Stimulus Patterns.

Authors:  L A Riggs; E P Johnson; A M Schick
Journal:  Science       Date:  1964-05-01       Impact factor: 47.728

Review 9.  People and eyes: statistical approaches in ophthalmology.

Authors:  I E Murdoch; S S Morris; S N Cousens
Journal:  Br J Ophthalmol       Date:  1998-08       Impact factor: 4.638

10.  Human cone photoreceptor responses measured by the electroretinogram [correction of electoretinogram] a-wave during and after exposure to intense illumination.

Authors:  A A Paupoo; O A Mahroo; C Friedburg; T D Lamb
Journal:  J Physiol       Date:  2000-12-01       Impact factor: 5.182

View more
  7 in total

1.  ALDH2 protects naturally aged mouse retina via inhibiting oxidative stress-related apoptosis and enhancing unfolded protein response in endoplasmic reticulum.

Authors:  Pan Long; Mengshan He; Weiming Yan; Wei Chen; Dongyu Wei; Siwang Wang; Zuoming Zhang; Wei Ge; Tao Chen
Journal:  Aging (Albany NY)       Date:  2020-12-19       Impact factor: 5.682

2.  Micro-incision vitrectomy surgery for primary rhegmatogenous retinal detachments with posterior vitreous detachments in elderly patients: Preoperative characteristics and surgical outcomes.

Authors:  Kazuya Yamashita; Saki Sakakura; Yoshiko Ofuji; Maho Sato; Takashi Nagamoto; Hirohisa Kubono; Mari Kawamura; Kotaro Suzuki
Journal:  PLoS One       Date:  2021-01-06       Impact factor: 3.240

3.  Retbindin mediates light-damage in mouse retina while its absence leads to premature retinal aging.

Authors:  Jianguo Fan; Dinusha Rajapakse; Katherine Peterson; Joshua Lerner; Shabnam Parsa; Arjun Ponduri; Vatsala Sagar; Todd Duncan; Lijin Dong; Graeme Wistow
Journal:  Exp Eye Res       Date:  2021-07-03       Impact factor: 3.770

4.  Focal electroretinogram and microperimetry testing of photoreceptor-retinal pigment epithelium function in intermediate age-related macular degeneration.

Authors:  Dario Messenio; Alessandro Babbi; Alessandra Guglielmi; Matteo Airaldi
Journal:  Acta Ophthalmol       Date:  2021-06-29       Impact factor: 3.988

5.  Alteration of retinal layers in healthy subjects over 60 years of age until nonagenarians.

Authors:  Lebriz Altay; Cheryl Jahn; Mücella Arikan Yorgun; Albert Caramoy; Tina Schick; Carel B Hoyng; Anneke I den Hollander; Sascha Fauser
Journal:  Clin Ophthalmol       Date:  2017-08-16

Review 6.  A glimpse at the aging eye.

Authors:  Jonathan B Lin; Kazuo Tsubota; Rajendra S Apte
Journal:  NPJ Aging Mech Dis       Date:  2016-03-10

7.  An Alternative Psychophysical Diagnostic Indicator of the Aging Eye.

Authors:  John D Rodriguez; Garrick Wallstrom; Divya Narayanan; Donna Welch; Mark B Abelson
Journal:  J Ophthalmol       Date:  2019-11-03       Impact factor: 1.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.